Abstract
The corneal epithelium metabolizes arachidonic acid by a cytochrome P-450 (CYP)-mediated activity to 12-hydroxy-5,8,11,14-eicosatetraenoic acid (12(R)-HETE) and 12-hydroxy-5,8,14-eicosatrienoic acid (12(R)-HETrE ). Both metabolites possess potent inflammatory properties, with 12(R)-HETrE being a powerful angiogenic factor, and they assume the role of inflammatory mediators in hypoxia- and chemical-induced injury in the cornea in vivo and in vitro. We used a model of corneal organ culture that exhibits hypoxia-induced epithelial CYP-dependent 12(R)-HETE and 12(R)-HETrE synthesis for isolating, identifying, and characterizing the CYP protein responsible for these eicosanoid syntheses. Northern analysis revealed the presence of a CYP4A-hybridizable mRNA, the levels of which were increased after hypoxia. Reverse transcription-polymerase chain reaction analysis with primers specific for the CYP4A family led to the isolation of a 671-base pair fragment with a 98.8% sequence homology to the rabbit lung CYP4B1 isoform, of which the levels in the corneal epithelium were greatly increased under hypoxic conditions. Moreover, phenobarbital, an inducer of hepatic CYP4B1 in the rabbit, also induced 12-HETE and 12-HETrE synthesis. Antibodies against CYP4B1, but not against CYP4A1, inhibited hypoxia-, clofibrate-, and phenobarbital-induced 12-HETE and 12-HETrE synthesis. These results suggest the involvement of a CYP4B1 isoform in the corneal epithelial synthesis of these eicosanoids in response to hypoxia.
Footnotes
-
Send reprint requests to: Michal Laniado Schwartzman, Ph.D., Department of Pharmacology, New York Medical College, Valhalla, NY 10595. E-mail: michal_schwartzman{at}nymc.edu
-
↵1 This study was supported by National Institutes of Health Grants EY06513 and HL34300.
- Abbreviations:
- CYP
- Cytochrome P-450
- 12-HETE
- 12-hydroxy-5,8,11,14-eicosatetraenoic acid
- 12-HETrE
- 12-hydroxy-5,8,14-eicosatrienoic acid
- RT
- reverse transcription
- PCR
- polymerase chain reaction
- DMEM
- Dulbecco’s modified Eagle’s medium
- PPAR
- peroxisomal proliferator-activating receptor
- bp
- base pair
- kb
- kilobase
- 11,12-EET
- 11,12-epoxyeicosatrienoic acid
- Received November 20, 1998.
- Accepted February 16, 1999.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|